ClinicalTrials.Veeva

Menu

Daily Oral L-arginine Plus Tadalafil in Diabetic Patients With Erectile Dysfunction

A

Aswan University Hospital

Status

Completed

Conditions

Erectile Dysfunction

Treatments

Diagnostic Test: HbA1C
Drug: L-arginine 5 gm oral caps
Device: penile doppler
Drug: Tadalafil 10 MG
Diagnostic Test: serum testosterone level

Study type

Interventional

Funder types

Other

Identifiers

NCT03834610
L-arginine

Details and patient eligibility

About

Tadalafil is an effective oral therapy in erectile dysfunction. L-arginine is a pro drug that increase the level of nitrous oxide in the smooth muscles so can increase the strength and duration of erection. this clinical trials compare the daily oral L-arginine plus tadalafil in treatment of erectile dysfunction in diabetic patients.

Enrollment

108 patients

Sex

Male

Ages

35 to 56 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • patients with type 2 DM

Exclusion criteria

  • Patients with history of pelvic trauma, major pelvic surgical intervention, hypogonadism, hyperprolactinemia, hypertension, chronic prostatitis, chronic liver disease, smokers, history of chronic intake of CNS or anti-androgen drugs and patients with Peyronie's Disease or any fibrotic anomalies

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

108 participants in 4 patient groups, including a placebo group

Group A
Active Comparator group
Description:
receive L-arginine 5 g oral caps daily for 8 weeks serum testosterone level measurement penile doppler
Treatment:
Device: penile doppler
Diagnostic Test: HbA1C
Drug: L-arginine 5 gm oral caps
Diagnostic Test: serum testosterone level
Group B
Active Comparator group
Description:
receive tadalafil 10 mg oral tablets daily for 8 weeks serum testosterone level measurement penile doppler
Treatment:
Device: penile doppler
Drug: Tadalafil 10 MG
Diagnostic Test: HbA1C
Diagnostic Test: serum testosterone level
Group C
Active Comparator group
Description:
receive L-arginine 5 g oral caps plus tadalafil 10 mg oral tablets daily for 8 weeks serum testosterone level measurement penile doppler
Treatment:
Device: penile doppler
Drug: Tadalafil 10 MG
Diagnostic Test: HbA1C
Drug: L-arginine 5 gm oral caps
Diagnostic Test: serum testosterone level
Group D
Placebo Comparator group
Description:
receive oral methyl cellulose daily for 8 weeks serum testosterone level measurement penile doppler
Treatment:
Device: penile doppler
Diagnostic Test: HbA1C
Diagnostic Test: serum testosterone level

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems